Global Information
회사소개 | 문의

세계의 말 헬스케어 시장(진단 제품, 치료 제품, 서플리먼트 제품) : 산업 분석, 규모, 점유율, 성장, 동향 및 예측

Equine Healthcare Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

리서치사 Transparency Market Research
발행일 2018년 02월 상품 코드 294617
페이지 정보 영문 244 Pages
가격
US $ 5,795 ₩ 6,608,000 PDF by E-mail (Single user license) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 인쇄는 가능하지만, 전체 페이지 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,795 ₩ 10,029,000 PDF by E-mail (5-user license) help
5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 전체 페이지 인쇄는 1명당 1회로 한정하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 11,795 ₩ 13,451,000 PDF by E-mail (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 말 헬스케어 시장(진단 제품, 치료 제품, 서플리먼트 제품) : 산업 분석, 규모, 점유율, 성장, 동향 및 예측 Equine Healthcare Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
발행일 : 2018년 02월 페이지 정보 : 영문 244 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 말 헬스케어(Equine Healthcare) 시장에 대해 조사하고, 시장 동향과 성장률, 시장 규모와 향후 예측, 지역별 동향, 경쟁 구도 등의 정보를 기업 개요와 함께 전해드립니다.

제1장 서론

제2장 주요 요약

제3장 말 헬스케어 시장 개요

  • 정의 : 말 헬스케어
  • 승마 산업의 중요성과 말 헬스케어
  • 시장 성장 촉진요인
    • 높은 투자회수율이 시장 진출을 촉진하여 시장이 확대
    • 다수의 지원 시장 및 2차 시장이 성장을 촉진
    • 새로운 지역이 경마에 투자
    • 말 헬스케어 기관 및 시장 참여자의 계획
  • 시장 성장 저해요인
    • 세계의 말 수 감소
    • 온라인 베팅/게임 등의 대체적 도박
  • 기회
    • 하위 부문 시장 : 기회 지표
    • 아시아태평양 시장 : 니치 시장
  • Porter's Five Forces 분석
  • 시장 매력도 분석 : 지역별

제4장 세계의 말 진단 제품 시장 : 종류별

  • 임신 진단 제품 시장
    • 초음파 장비 시장
    • 소변 검사 키트 시장

제5장 세계의 말 치료 제품 시장 : 종류별

  • 백신 시장
  • 치료 제품 시장

제6장 세계의 말 서플리먼트 제품 시장 : 종류별

  • 퍼포먼스 서플리먼트(Performance Supplements) 시장
  • 보호 제품 시장

제7장 세계의 말 헬스케어 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양 지역
  • 기타 국가

제8장 기업 개요

  • Affymetrix, Inc.
  • Bayer
  • Boerhringer Ingelheim Vetmedica, Inc. (BIVI)
  • Elanco Animal Health
  • Equine Diagnostics
  • Equine Orthotics and Prosthetics
  • Equine Products (UK) Ltd.
  • Merck Animal Health
  • Purina Mills, LLC
  • Signostics Limited
  • Zoetis, Inc.

도표

KSM 14.02.14

List of Tables

  • Table 01: Global Equine Healthcare Market (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 02: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Drug Type, 2015-2025
  • Table 03: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Vaccine Type, 2015-2025
  • Table 04: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Supplemental Feed Additives Type, 2015-2025
  • Table 05: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 06: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2015-2025
  • Table 07: Global Equine Healthcare Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 08: North America Equine Healthcare Market, Product Pricing (USS) Analysis, 2015-2025
  • Table 09: North America Equine Healthcare Market (US$ Mn) Forecast, by Country, 2015-2025
  • Table 10: North America Equine Healthcare Market (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 11: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Drug Type, 2015-2025
  • Table 12: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Vaccine Type, 2015-2025
  • Table 13: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Supplemental Feed Additive Type, 2015-2025
  • Table 14: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 15: North America Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2015-2025
  • Table 16: Europe Equine Healthcare Market, Product Pricing (US$) Analysis, 2015-2025
  • Table 17: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Country/, 2015-2025
  • Table 18: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Product, 2015-2025
  • Table 19: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Drug Type, 2015-2025
  • Table 20: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Vaccine Type, 2015-2025
  • Table 21: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Supplemental Feed Additives, 2015-2025
  • Table 22: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 23: Europe Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2015-2025
  • Table 24: Asia Pacific Equine Healthcare Market, Product Pricing (US$) Analysis, 2015-2025
  • Table 25: Asia Pacific Equine Healthcare Market (US$ Mn) Forecast, by Country/, 2015-2025
  • Table 26: Asia Pacific Equine Healthcare Market (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 27: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Drug Type, 2015-2025
  • Table 28: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Vaccine Type, 2015-2025
  • Table 29: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Supplemental Feed Additives Type, 2015-2025
  • Table 30: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 31: Asia Pacific Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2015-2025
  • Table 32: Latin America Equine Healthcare Market, Product Pricing (US$) Analysis, 2015-2025
  • Table 33: Latin America Equine Healthcare Market (US$ Mn) Forecast, by Country, 2015-2025
  • Table 34: Latin America Equine Healthcare Market (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 35: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Drug Type, 2015-2025
  • Table 36: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Vaccine Type, 2015-2025
  • Table 37: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Supplemental Feed Additives Type, 2015-2025
  • Table 38: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 39: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2015-2025
  • Table 40: Middle East & Africa Equine Healthcare Market, Product Pricing (US$) Analysis, 2015-2025
  • Table 41: Middle East & Africa Equine Healthcare Market (US$ Mn) Forecast, by Country, 2015-2025
  • Table 42: Middle East & Africa Equine Healthcare Market (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 43: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Drug Type, 2015-2025
  • Table 44: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Vaccine Type, 2015-2025
  • Table 45: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Supplemental Feed Additives Type, 2015-2025
  • Table 46: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Distribution Channel, 2015-2025
  • Table 47: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, by Disease Type, 2015-2025

List of Figures

  • Figure 1: Global Equine Health Care Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 2: Global Equine Healthcare Market Value Share, by Product Type, 2016 and 2025
  • Figure 3: Global Equine Healthcare Market, by Product Type, 2016-2025
  • Figure 4: Global Equine Healthcare Market Revenue, (US$ Mn), forecast, by Drugs segment, 2015-2025
  • Figure 5: Global Equine Healthcare Market Revenue, (US$ Mn), forecast, by Vaccines Segment, 2015-2025
  • Figure 6: Global Equine Healthcare Market Revenue, (US$ Mn), forecast, by Supplemental Feed Additive Segment, 2015-2025
  • Figure 7: Global Equine Healthcare Market Value Share, by Drug Type, 2016 and 2025
  • Figure 8: Global Equine Healthcare Market Attractiveness Analysis, by Drug Type, 2016-2025
  • Figure 9: Global Equine Healthcare Market Value Share, by Vaccine Type, 2016 and 2025
  • Figure 10: Global Equine Healthcare Market Attractiveness Analysis, by Vaccine Type, 2016-2025
  • Figure 11: Global Equine Healthcare Market Value Share, by Supplemental Feed Additives Type, 2016 and 2025
  • Figure 12: Global Equine Healthcare Market Attractiveness Analysis, by Supplemental Feed Additives Type, 2016-2025
  • Figure 13: Global Equine Healthcare Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 14: Global Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2016-2025
  • Figure 15: Global Equine Healthcare Market, Revenue (US$ Mn), Forecast, by Veterinary Hospitals and clinics Segment, 2015-2025
  • Figure 16: Global Equine Healthcare Market Revenue (US$ Mn) Forecast, by Retail Pharmacies and Drug Stores Segment, 2015-2025
  • Figure 17: Global Equine Healthcare Market Revenue (US$ Mn), Forecast, by Others Segment, 2015-2025
  • Figure 18: Global Equine Healthcare Market Value Share, by Disease Type, 2016 and 2025
  • Figure 19: Global Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2016-2025
  • Figure 20: Global Equine Healthcare Market, Revenue (US$ Mn), Forecast, by West Nile Virus Segment, 2015-2025
  • Figure 21: Global Equine Healthcare Market Revenue (US$ Mn) Forecast, by Equine Rabies Segment, 2015-2025
  • Figure 22: Global Equine Healthcare Market Revenue (US$ Mn), Forecast, by Potomac Horse Fever Segment, 2015-2025
  • Figure 23: Global Equine Healthcare Market, Revenue (US$ Mn), Forecast, by Tetanus Segment, 2015-2025
  • Figure 24: Global Equine Healthcare Market Revenue (US$ Mn) Forecast, by Equine Influenza Segment, 2015-2025
  • Figure 25: Global Equine Healthcare Market Revenue (US$ Mn), Forecast, by Equine Herpes Virus Segment, 2015-2025
  • Figure 26: Global Equine Healthcare Market, Revenue, (US$ Mn) Forecast, by Equine Encephalomyelitis Segment, 2015-2025
  • Figure 27: Global Equine Healthcare Market, Revenue, (US$ Mn) Forecast, by Others Segment, 2015-2025
  • Figure 28: Global Equine Healthcare Market Value Share, by Region, 2016 and 2025
  • Figure 29: Global Equine Healthcare Market Attractiveness Analysis, by Country, 2017-2025
  • Figure 30: North America Equine Healthcare Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 31: North America Equine Healthcare Market Value Share, by Country, 2016 and 2025
  • Figure 32: North America Equine Healthcare Market, by Country, 2016-2025
  • Figure 33: North America Equine Healthcare Market Value Share, by Product Type, 2016 and 2025
  • Figure 34: North America Equine Healthcare Market, by Product Type, 2016-2025
  • Figure 35: North America Equine Healthcare Market Value Share, by Drug Type, 2016 and 2025
  • Figure 36: North America Equine Healthcare Market Attractiveness Analysis, by Drug Type, 2016-2025
  • Figure 37: North America Equine Healthcare Market Value Share, by Vaccine Type, 2016 and 2025
  • Figure 38: North America Equine Healthcare Market Attractiveness Analysis, by Vaccine Type, 2016-2025
  • Figure 39: North America Equine Healthcare Market Value Share, by Supplemental Feed Additive Type, 2016 and 2025
  • Figure 40: North America Equine Healthcare Market Attractiveness Analysis, by Supplemental Feed Additive Type, 2016-2025
  • Figure 41: North America Equine Healthcare Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 42: North America Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2016-2025
  • Figure 43: North America Equine Healthcare Market Value Share, by Disease Type, 2016 and 2025
  • Figure 44: North America Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2016-2025
  • Figure 45: Europe Equine Healthcare Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 46: Europe Equine Healthcare Market Value Share, by Country/, 2016 and 2025
  • Figure 47: Europe Equine Healthcare Market Attractiveness, by Country/, 2016-2025
  • Figure 48: Europe Equine Healthcare Market Value Share, by Product, 2016 and 2025
  • Figure 49: Europe Equine Healthcare Market Attractiveness, by Product, 2016-2025
  • Figure 50: Europe Equine Healthcare Market Value Share, by Drug Type, 2016 and 2025
  • Figure 51: Europe Equine Healthcare Market Attractiveness, by Drug Type, 2016-2025
  • Figure 52: Europe Equine Healthcare Market Value Share, by Vaccine Type, 2016 and 2025
  • Figure 53: Europe Equine Healthcare Market Attractiveness, by Vaccine Type, 2016-2025
  • Figure 54: Europe Equine Healthcare Market Value Share, by Supplemental Feed Additives, 2016 and 2025
  • Figure 55: Europe Equine Healthcare Market Attractiveness, by Supplemental Feed Additives, 2016-2025
  • Figure 56: Europe Equine Healthcare Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 57: Europe Equine Healthcare Market Attractiveness, by Distribution Channel, 2016-2025
  • Figure 58: Europe Equine Healthcare Market Value Share, by Disease Type, 2016 and 2025
  • Figure 59: Europe Equine Healthcare Market Attractiveness, by Disease Type, 2016-2025
  • Figure 60: Asia Pacific America Equine Healthcare Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 61: Asia Pacific Equine Healthcare Market Value Share, by Country/, 2016 and 2025
  • Figure 62: Asia Pacific Equine Healthcare Market, by Country/, 2016-2025
  • Figure 63: Asia Pacific Equine Healthcare Market Value Share, by Product Type, 2016 and 2025
  • Figure 64: Asia Pacific Equine Healthcare Market, by Product Type, 2016-2025
  • Figure 65: Asia Pacific Equine Healthcare Market Value Share, by Drug Type, 2016 and 2025
  • Figure 66: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Drug Type, 2016-2025
  • Figure 67: Asia Pacific Equine Healthcare Market Value Share, by Vaccine Type, 2016 and 2025
  • Figure 68: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Vaccine Type, 2016-2025
  • Figure 69: Asia Pacific Equine Healthcare Market Value Share, by Supplemental Feed Additives Type, 2016 and 2025
  • Figure 70: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Supplemental Feed Additives Type, 2016-2025
  • Figure 71: Asia Pacific Equine Healthcare Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 72: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2016-2025
  • Figure 73: Asia Pacific Equine Healthcare Market Value Share, by Disease Type, 2016 and 2025
  • Figure 74: Asia Pacific Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2016-2025
  • Figure 75: Latin America Equine Healthcare Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 76: Latin America Equine Healthcare Market Value Share, by Country, 2016 and 2025
  • Figure 77: Latin America Equine Healthcare Market, by Country, 2016-2025
  • Figure 78: Latin America Equine Healthcare Market Value Share, by Product Type, 2016 and 2025
  • Figure 79: Latin America Equine Healthcare Market, by Product Type, 2016-2025
  • Figure 80: Latin America Equine Healthcare Market Value Share, by Drug Type, 2016 and 2025
  • Figure 81: Latin America Equine Healthcare Market Attractiveness Analysis, by Drug Type, 2016-2025
  • Figure 82: Latin America Equine Healthcare Market Value Share, by Vaccine Type, 2016 and 2025
  • Figure 83: Latin America Equine Healthcare Market Attractiveness Analysis, by Vaccine Type, 2016-2025
  • Figure 84: Latin America Equine Healthcare Market Value Share, by Supplemental Feed Additives Type, 2016 and 2025
  • Figure 85: Latin America Equine Healthcare Market Attractiveness Analysis, by Supplemental Feed Additives Type, 2016-2025
  • Figure 86: Latin America Equine Healthcare Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 87: Latin America Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2016-2025
  • Figure 88: Latin America Equine Healthcare Market Value Share, by Disease Type, 2016 and 2025
  • Figure 89: Latin America Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2016-2025
  • Figure 90: Middle East & Africa Equine Healthcare Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 91: Middle East & Africa Equine Healthcare Market Value Share, by Country, 2016 and 2025
  • Figure 92: Middle East & Africa Equine Healthcare Market, by Country, 2016-2025
  • Figure 93: Middle East & Africa Equine Healthcare Market Value Share, by Product Type, 2016 and 2025
  • Figure 94: Middle East & Africa Equine Healthcare Market, by Product Type, 2016-2025
  • Figure 95: Middle East & Africa Equine Healthcare Market Value Share, by Drug Type, 2016 and 2025
  • Figure 96: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Drug Type, 2016-2025
  • Figure 97: Middle East & Africa Equine Healthcare Market Value Share, by Vaccine Type, 2016 and 2025
  • Figure 98: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Vaccine Type, 2016-2025
  • Figure 99: Middle East & Africa Equine Healthcare Market Value Share, by Supplemental Feed Additives Type, 2016 and 2025
  • Figure 100: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Supplemental Feed Additives Type, 2016-2025
  • Figure 101: Middle East & Africa Equine Healthcare Market Value Share, by Distribution Channel, 2016 and 2025
  • Figure 102: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Distribution Channel, 2016-2025
  • Figure 103: Middle East & Africa Equine Healthcare Market Value Share, by Disease Type, 2016 and 2025
  • Figure 104: Middle East & Africa Equine Healthcare Market Attractiveness Analysis, by Disease Type, 2016-2025
  • Figure 105: Market Share of Prominent Key Players in the Global Equine Health Market, 2016

Global Equine Healthcare Market: Overview

This report provides in-depth region wise and country wise analysis of the equine healthcare market. Stakeholders of this report include manufacturers of veterinary products, industry practitioners, research professionals, and new players planning to enter the market.

The report provides qualitative and quantitative analysis of the global equine healthcare market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes market share held by companies, market size, and forecast for the global equine healthcare market in major countries. Market revenue is provided in terms of US$ Mn from 2015 to 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 for all the segments, considering 2016 as the base year. The executive summary of the report provides a snapshot of the equine healthcare market with information on leading segments and sub-segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors.

The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global equine healthcare market. These factors would aid the stakeholders in establishing a strong foothold in the global equine healthcare market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the equine healthcare products. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.

Global Equine Healthcare Market: Segmentation

The equine healthcare market has been extensively analyzed on basis of the product type (drugs, vaccines and supplemental feed additives), disease type and distribution channel, and geography. The market by product type is further segmented as drugs, vaccines and supplemental feed additives. The drugs sub-segment is classified into anti-infectives, anti-inflmmatory, paracititidis and others whereas the vaccines sub-segment is categorized into inactivated, live attenuated, recombinant and others. Additionally, the supplemental feed additives type sub-segment is segmented into minerals, vitamins, proteins and amino acids, enzyme, others. The distribution channel segment has been classified into veterinary hospitals and clinics, retail pharmacies and drug stores and others. Furthermore, the market by disease type is classified into west nile virus, equine rabies, potomac horse fever, tetanus, equine influenza, equine herpes virus, equine encephalomyelitis, others.

By geography, the equine healthcare market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Spain, Italy, Japan, China, India, Australia and New Zealand, Brazil, Mexico, GCC (Gulf Cooperation Council) and South Africa have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the equine healthcare market in various regions have been provided in this section. This report also includes various ups and downs about particular country or geography that has impacted the overall market globally.

Global Equine Healthcare Market: Competitive Dynamics

The report provides a detailed outline/blueprint of the equine healthcare market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. Prominent key players are Bayer AG (Bayer Animal Health), Boehringer Ingelheim, Ceva Sante Animale , Eli Lilly and Company (Elanco) , EQUINE PRODUCTS UK LTD , Merck & Co. (Merck Animal Health), Sanofi (Merial), Purina Animal Nutrition LLC., Vetoquinol S.A. and Zoetis.

The global equine healthcare market is segmented as given below:

Global Equine Healthcare Market, by Product Type

  • Drugs
    • Anti-infectives
    • Anti-inflammatory
    • Parasiticides
    • Others
  • Vaccine
    • Inactivated
    • Live Attenuated
    • Recombinant
    • Others
  • Supplemental Feed additives
    • Proteins and amino acids
    • Vitamins
    • Enzymes
    • Minerals
    • Others

Global Equine Healthcare Market, by Disease Type

  • Equine Influenza
  • Equine Herpes virus
  • Equine Encephalomyelitis
  • West Nile Virus
  • Equine Rabies
  • Potomac Horse Fever
  • Tetanus
  • Others

Global Equine Healthcare Market, by Distribution Channel

  • Veterinary Hospitals and Clinics
  • Retail Pharmacies and Drug Stores
  • Others

Global Equine Healthcare Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Research Highlights
  • 1.3. Assumptions and Acronyms Used

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Market Overview

  • 4.1. Market Segmentation
  • 4.2. Industry Evolution/Developments
  • 4.3. Overview: Global Equine Health Care Market Analysis, Revenue (US$ Mn) and Forecast
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
      • 4.4.1.1. The equine industry has strong impact on overall economy
      • 4.4.1.2. High incidence of equine infections
      • 4.4.1.3. Initiatives by equine health care organizations and market participants
    • 4.4.2. Restrains
      • 4.4.2.1. Decline in global equine population
    • 4.4.3. Opportunities
      • 4.4.3.1. Rise in demand for pet insurance
    • 4.4.4. Supply-Demand Scenario of Equine Healthcare Market
    • 4.4.5. Porter's Five Forces Analysis
    • 4.4.6. Value Chain Analysis
    • 4.4.7. Animal Health Care Overview
    • 4.4.8. Global Equine Disease Prevalence, 2016
    • 4.4.9. Policies and Regulations
    • 4.4.10. Success Stories of Top 3 Players
    • 4.4.11. Key Decision Makers and Selection Criteria
    • 4.4.12. Key Brand Analysis
    • 4.4.13. Applied SWOT

Chapter 5. Global Equine Healthcare Market Analysis and Forecasts, By Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
  • 5.3. Global Equine Healthcare Market share and Market Attractiveness Analysis, by Product Type
    • 5.3.1. Global Equine Healthcare Market share and Market Attractiveness Analysis, by Drug Type
      • 5.3.1.1. Anti-Infectives
      • 5.3.1.2. Anti-Inflammatory
      • 5.3.1.3. Parasiticides
      • 5.3.1.4. Others
    • 5.3.2. Global Equine Healthcare Market share and Market Attractiveness Analysis, by Vaccine Type
      • 5.3.2.1. Inactivated
      • 5.3.2.2. Live Attenuated
      • 5.3.2.3. Recombinant
      • 5.3.2.4. Others
    • 5.3.3. Global Equine Healthcare Market share and Market Attractiveness Analysis, by Supplemental Feed Additives Type
      • 5.3.3.1. Minerals
      • 5.3.3.2. Vitamins
      • 5.3.3.3. Proteins and Amino Acids
      • 5.3.3.4. Enzymes
      • 5.3.3.5. Others
  • 5.4. Key Trends

Chapter 6. Global Equine healthcare Market Analysis, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. Global Equine Healthcare Market share and Market Attractiveness Analysis, by Distribution Channel
    • 6.3.1. Veterinary Hospitals and Clinics
    • 6.3.2. Retail Pharmacies and Drug Stores
    • 6.3.3. Others
  • 6.4. Key Trends

Chapter 7. Global Equine healthcare Market Analysis, by Disease Type

  • 7.1. Key Findings
  • 7.2. Introduction
  • 7.3. Global Equine Healthcare Market share and Market Attractiveness Analysis, by Disease Type
    • 7.3.1. West Nile Virus
    • 7.3.2. Equine Rabies
    • 7.3.3. Potomac Horse Fever
    • 7.3.4. Tetanus
    • 7.3.5. Equine Influenza
    • 7.3.6. Equine Herpes Virus
    • 7.3.7. Equine
  • 7.4. Key Trends

Chapter 8. Global Equine healthcare Market Analysis, by Region

  • 8.1. Geographical Scenario
  • 8.2. Global Equine Healthcare Market Analysis, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Global Equine Healthcare Market: Regional Trends

Chapter 9. North America Equine healthcare Market Analysis

  • 9.1. Key Findings
  • 9.2. Overview: North America Equine Healthcare Market Revenue (US$) Forecast
  • 9.3. Pricing Trend: North America Equine Healthcare Market
  • 9.4. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Country
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Product Type
  • 9.6. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Drug Type
  • 9.7. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Vaccine Type
  • 9.8. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Supplemental Feed Additives Type
  • 9.9. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Distribution Channel
  • 9.10. North America Equine Healthcare Market share and Market Attractiveness Analysis, by Disease Type
  • 9.11. Market Attractiveness Analysis
    • 9.11.1. By Country
    • 9.11.2. By Product Type
    • 9.11.3. By Distribution Channel
    • 9.11.4. By Disease Type
  • 9.12. Key Trends

Chapter 10. Europe Equine healthcare Market Analysis

  • 10.1. Key Findings
  • 10.2. Overview: Europe Equine Healthcare Market Revenue (US$) Forecast
  • 10.3. Pricing Trend: Europe Equine Healthcare Market
  • 10.4. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Country
    • 10.4.1. U.K.
    • 10.4.2. France
    • 10.4.3. Germany
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Product Type
  • 10.6. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Drug Type
  • 10.7. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Vaccine Type
  • 10.8. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Supplemental Feed Additives Type
  • 10.9. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Distribution Channel
  • 10.10. Europe Equine Healthcare Market share and Market Attractiveness Analysis, by Disease Type
  • 10.11. Market Attractiveness Analysis
    • 10.11.1. By Country
    • 10.11.2. By Product Type
    • 10.11.3. By Distribution Channel
    • 10.11.4. By Disease Type
  • 10.12. Key Trends

Chapter 11. Asia Pacific Equine healthcare Market Analysis

  • 11.1. Key Findings
  • 11.2. Overview: Asia Pacific Equine Healthcare Market Revenue (US$) Forecast
  • 11.3. Pricing Trend: Asia Pacific Equine Healthcare Market
  • 11.4. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Country
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia and New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Product Type
  • 11.6. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Drug Type
  • 11.7. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Vaccine Type
  • 11.8. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Supplemental Feed Additives Type
  • 11.9. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Distribution Channel
  • 11.10. Asia Pacific Equine Healthcare Market share and Market Attractiveness Analysis, by Disease Type
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Country
    • 11.11.2. By Product Type
    • 11.11.3. By Distribution Channel
    • 11.11.4. By Disease Type
  • 11.12. Key Trends

Chapter 12. Latin America Equine healthcare Market Analysis

  • 12.1. Key Findings
  • 12.2. Overview: Latin America Equine Healthcare Market Revenue (US$) Forecast
  • 12.3. Pricing Trend: Latin America Equine Healthcare Market
  • 12.4. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Country
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Product Type
  • 12.6. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Drug Type
  • 12.7. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Vaccine Type
  • 12.8. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Supplemental Feed Additives Type
  • 12.9. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Distribution Channel
  • 12.10. Latin America Equine Healthcare Market share and Market Attractiveness Analysis, by Disease Type
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Country
    • 12.11.2. By Product Type
    • 12.11.3. By Distribution Channel
    • 12.11.4. By Disease Type
  • 12.12. Key Trends

Chapter 13. Middle East & Africa Equine healthcare Market Analysis

  • 13.1. Key Findings
  • 13.2. Overview: Middle East & Africa Equine Healthcare Market Revenue (US$) Forecast
  • 13.3. Pricing Trend: Middle East & Africa Equine Healthcare Market
  • 13.4. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Country
    • 13.4.1. GCC
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East and Africa
  • 13.5. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Product Type
  • 13.6. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Drug Type
  • 13.7. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Vaccine Type
  • 13.8. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Supplemental Feed Additives Type
  • 13.9. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Distribution Channel
  • 13.10. Middle East & Africa Equine Healthcare Market share and Market Attractiveness Analysis, by Disease Type
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Country
    • 13.11.2. By Product Type
    • 13.11.3. By Distribution Channel
    • 13.11.4. By Disease Type
  • 13.12. Key Trends

Chapter 14. Competition Landscape

  • 14.1. Competition Matrix
  • 14.2. Market Share Analysis
  • 14.3. Company Profiles
    • 14.3.1. Bayer AG (Bayer Animal Health)
      • 14.3.1.1. Company Details
      • 14.3.1.2. Company Description
      • 14.3.1.3. Business Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Financial Analysis
      • 14.3.1.6. Strategic Overview
    • 14.3.2. Boehringer Ingelheim
      • 14.3.2.1. Company Details
      • 14.3.2.2. Company Description
      • 14.3.2.3. Business Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Financial Analysis
      • 14.3.2.6. Strategic Overview
    • 14.3.3. Ceva Sante Animale
      • 14.3.3.1. Company Details
      • 14.3.3.2. Company Description
      • 14.3.3.3. Business Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Financial Analysis
      • 14.3.3.6. Strategic Overview
    • 14.3.4. Eli Lilly and Company (Elanco)
      • 14.3.4.1. Company Details
      • 14.3.4.2. Company Description
      • 14.3.4.3. Business Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Financial Analysis
      • 14.3.4.6. Strategic Overview
    • 14.3.5. EQUINE PRODUCTS U.K. LTD
      • 14.3.5.1. Company Details
      • 14.3.5.2. Company Description
      • 14.3.5.3. Business Overview
      • 14.3.5.4. SWOT Analysis
      • 14.3.5.5. Financial Analysis
      • 14.3.5.6. Strategic Overview
    • 14.3.6. Merck & Co. (Merck Animal Health)
      • 14.3.6.1. Company Details
      • 14.3.6.2. Company Description
      • 14.3.6.3. Business Overview
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Financial Analysis
      • 14.3.6.6. Strategic Overview
    • 14.3.7. Sanofi (Merial)
      • 14.3.7.1. Company Details
      • 14.3.7.2. Company Description
      • 14.3.7.3. Business Overview
      • 14.3.7.4. SWOT Analysis
      • 14.3.7.5. Financial Analysis
      • 14.3.7.6. Strategic Overview
    • 14.3.8. Purina Animal Nutrition LLC
      • 14.3.8.1. Company Details
      • 14.3.8.2. Company Description
      • 14.3.8.3. Business Overview
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Financial Analysis
      • 14.3.8.6. Strategic Overview
    • 14.3.9. Vetoquinol S.A.
      • 14.3.9.1. Company Details
      • 14.3.9.2. Company Description
      • 14.3.9.3. Business Overview
      • 14.3.9.4. SWOT Analysis
      • 14.3.9.5. Financial Analysis
      • 14.3.9.6. Strategic Overview
    • 14.3.10. Zoetis
      • 14.3.10.1. Company Details
      • 14.3.10.2. Company Description
      • 14.3.10.3. Business Overview
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Financial Analysis
      • 14.3.10.6. Strategic Overview
Back to Top
전화 문의
이용안내
 
BCC Research